Four US representatives introduced an amendment to the Justice Department appropriations bill, House Resolution 5326, which would bar the agency from spending funds to attack medical marijuana operations in states where it is legal. The bill was being considered Wednesday, before failing on a voice vote Wednesday evening.

A roll call vote was taken later, with the amendment failing 163-262 — 50 Democrats opposed it and 28 Republicans supported it. While the total number of “ayes” was almost identical to the last time the amendment was offered several years ago, that reflects the larger number of Republicans in the House. Both Democrats and Republicans voted for the amendment in greater percentages than in the past. [Ed: We will publish analysis of the voting breakdown this week.]

The House heard Reps. Barney Frank (D-MA), Maurice Hinchey (D-NY), Dana Rohrabacher (R-CA), Jerold Nadler (D-NY), and Steve Cohen (D-TN) speak in favor of the amendment, while the most notable opposition came from committee Chairman Frank Wolf (R-VA).

Hinchey was a cosponsor of the amendment, as was Rohrabacher, of Huntington Beach, and his California colleagues Reps. amie Farr (D-Carmel) and Tom McClintock (R-Auburn).

As a presidential candidate, then-Senator Obama said his administration would not use its resources to undermine state medical marijuana laws, especially if people were following their state’s law. At first, the administration lived up to his word. Shortly after he was elected president, the Department of Justice issued a memorandum to US Attorneys urging them not to waste taxpayer dollars and law enforcement resources arresting and prosecuting people following their state’s medical marijuana law.

CONTINUED at Stop the Drug War.

Thousands of pills filled with powdered human flesh have been discovered by customs officials in South Korea, it was revealed today.

The capsules are in demand because they are viewed as being a medicinal ‘cure-all’.

The grim trade is being run from China where corrupt medical staff are said to be tipping off medical companies when babies are aborted or delivered still-born.

The tiny corpses are then bought, stored in household refrigerators in homes of those involved in the trade before they are removed and taken to clinics where they are placed in medical drying microwaves.

The discoveries since last August has shocked even hardened customs agents who have pledged to strengthen inspections.

There is a huge demand for alternative Chinese remedies – which include ground up rhino horns. The Chinese have historically consumed human placentas to improve blood supply and circulation.

Health authorities in Asia are concerned that if the powdered foetus trade is allowed to continue the capsules will find their way onto the internet and be sold to gullible or sick desperate people in other parts of the world.

The South Korean Customs Service said today that it had heightened its searches of suspicious packages being brought into the country by travellers from China in an attempt to stamp out the sickening trade.

According to customs agents, 35 smuggling attempts have been made since August last year involving more than 17,000 capsules disguised as ‘stamina boosters’.

Hospitals and abortion clinics in China reportedly pass the remains onto drugs companies when a baby is stillborn or aborted, the South Korean SBS documentary team reported last year.
The San Francisco Times reported that tests carried out on the pills confirmed they were made up of 99.7 per cent human remains.

The tests were successfully able to establish the genders of the babies used.

There is a huge demand for the pills which are thought to enhance stamina. Microwave-dried placenta is also sought after for its alleged ‘medicinal’ benefits.

However, in reality the human flesh capsules contain super-bacteria and other harmful ingredients.

There have been disturbing reports that some babies were those who had perished in China’s notorious ‘dying rooms’ where youngsters are deliberately left to die because they were born into families that already had the limit of one child in country areas. …

Despite their disgust at discovering packets of the so-called rejuvenation pills being brought in from China, South Korean officials have refused to confirm where the babies came from or who made the capsules.

Sources said this was because they were not prepared to create diplomatic friction with Beijing, preferring to leave it to Chinese officials to do something about the horrific trade in powdered babies.

Source: The Daily Mail.

Researchers from the University of Minnesota’s Lillehei Heart Institute have effectively treated muscular dystrophy in mice using human stem cells derived from a new process that — for the first time — makes the production of human muscle cells from stem cells efficient and effective.

The research, published May 4 inCell Stem Cell, outlines the strategy for the development of a rapidly dividing population of skeletal myogenic progenitor cells (muscle-forming cells) derived from induced pluripotent (iPS) cells. iPS cells have all of the potential of embryonic stem (ES) cells, but are derived by reprogramming skin cells. They can be patient-specific, which renders them unlikely to be rejected, and do not involve the destruction of embryos.

This is the first time that human stem cells have been shown to be effective in the treatment of muscular dystrophy.

CONTINUED at Science Daily.

In a move that could help the government trim its burgeoning health care costs, the Food and Drug Administration may soon permit Americans to obtain some drugs used to treat conditions such as high blood pressure and diabetes without obtaining a prescription.

The FDA says over-the-counter distribution would let patients get drugs for many common conditions without the time and expense of visiting a doctor, but medical providers call the change medically unsound and note that it also may mean that insurance no longer will pay for the drugs.

“The problem is medicine is just not that simple,” said Dr. Matthew Mintz, an internist at George Washington University Hospital. “You can’t just follow rules and weigh all the pros and cons. It needs to be individualized.”

Under the changes that the agency is considering, patients could diagnose their ailments by answering questions online or at a pharmacy kiosk in order to buy current prescription-only drugs for conditions such as high cholesterol, certain infections, migraine headaches, asthma or allergies.

CONTINUED at the Washington Times.

A New York woman who donated a kidney so her ailing boss would move up the transplant waiting list says she was fired shortly after the operation, according to a complaint she filed with the New York State Division of Human Rights.

Deborah Stevens said her former employer, Atlantic Automotive Group, discriminated against her over disabilities brought about by complications from the surgery, and she plans to sue the company for lost earnings and damages.

The company, which runs car dealerships on Long Island, said Stevens’s complaint is groundless.

“My gal is just a good-natured woman who’s trying to save a life and as soon as she did it, everything changed,” said Stevens’ attorney Lenard Leeds on Tuesday.

“When she wanted to take time off, she was scolded, she was yelled at,” he said. “Instead of being sympathetic, they were very hostile towards her.”

Stevens, of Hicksville, New York, said she learned that Jacqueline Brucia, who worked at Atlantic Automotive, was in need of a kidney in November 2010. Stevens had worked there as well but at the time had temporarily moved to Florida.

Stevens said she told Brucia she would donate a kidney.

“Brucia declined, but told her, ‘You never know, I may have to take you up on that offer one day,’” the complaint said.

Stevens learned the company would rehire her following her return to New York and not long afterward, Brucia told her a potential donor had not been approved by the hospital and asked if she was still willing to donate.

Stevens now believes Brucia was “grooming (Stevens) to be her ‘back-up plan,’” the complaint said.

Stevens’s kidney was not a good match for Brucia, but she agreed to donate it to a stranger in St. Louis, Missouri, setting up a transplant chain that enabled Brucia to receive a better-matched kidney from a donor in San Francisco.

Surgeons removed Stevens’s left kidney in August, and she returned to work about a month later. The surgery left her with damaged nerves in her leg, digestive problems and mental health issues, her lawyer said.

At work, Brucia became “curt and dismissive,” the complaint said. Stevens said she was berated for taking sick days and forced to relocate to a less desirable office after she complained to human resources about Brucia’s behavior.

On April 11, the company fired her, citing performance reasons.

Stevens’s lawyer said the complaint filed with the Division of Human Rights last week was a necessary step before a federal lawsuit is filed against Brucia and the company.

Telephone calls to Brucia’s home were not answered on Tuesday.

Atlantic Automotive released a statement saying: “It is unfortunate that one employee has used her own generous act to make up a groundless claim.

“Atlantic Auto treated her appropriately and acted honorably and fairly, at every turn,” it said. …

Source: Reuters.

Call it President Obama’s Committee for the Re-Election of the President — a political slush fund at the Health and Human Services Department.

Only this isn’t some little fund from shadowy private sources; this is taxpayer money, redirected to help Obama win another term. A massive amount of it, too — $8.3 billion. Yes, that’s billion, with a B.

Here is how it works.

The most oppressive aspects of the ObamaCare law don’t kick in until after the 2012 election, when the president will no longer be answerable to voters. More “flexibility,” he recently explained to the Russians.

CONTINUED at the NY Post.

The therapy, which targets a molecule found in 90 per cent of all cancers, could provide a universal injection that allows patients’ immune systems to fight off common cancers including breast and prostate cancer.

Preliminary results from early clinical trials have shown the vaccine can trigger an immune response in patients and reduce levels of disease.

The scientists behind the vaccine now hope to conduct larger trials in patients to prove it can be effective against a range of different cancers.

They believe it could be used to combat small tumours if they are detected early enough or to help prevent the return and spread of disease in patients who have undergone other forms of treatment such as surgery.

Cancer cells usually evade patient’s immune systems because they are not recognised as being a threat. While the immune system usually attacks foreign cells such as bacteria, tumours are formed of the patient’s own cells that have malfunctioned.

Scientists have, however, found that a molecule called MUC1, which is found in high amounts on the surface of cancer cells, can be used to help the immune system detect tumours.

The new vaccine, developed by drug company Vaxil Biotheraputics along with researchers at Tel Aviv University, uses a small section of the molecule to prime the immune system so that it can identify and destroy cancer cells.

A statement from Vaxil Biotheraputics said: “ImMucin generated a robust and specific immune response in all patients which was observed after only 2-4 doses of the vaccine out of a maximum of 12 doses.

“In some of the patients, preliminary signs of clinical efficacy were observed.”

The results are still to be formally published but if further trials prove to be successful the vaccine could be available within six years.

As a therapeutic vaccine it is designed to be given to patients who are already suffering from cancer to help their bodies fight off the disease rather than to prevent disease in the first place.

Cancer cells contain high levels of MUC1 as it is thought to be involved helping tumours grow. Healthy human cells also contain MUC1, but have levels that are too low to trigger the immune system after vaccination.

When a vaccinated patient’s immune system encounters cancer cells, however, the far larger concentration of MUC1 causes it to attack and kill the tumour.

As MUC1 is found in 90 per cent of all cancers, the researchers believe it could be used to combat the growth and spread of a wide range of cancers.

In a safety trial at the Hadassah Medical Centre in Jerusalem, ten patients suffering from multiple myeloma, a form of blood cancer, have now received the vaccine.

Seven of the patients have now finished the treatment and Vaxil reported that all of them had greater immunity against cancer cells compared to before they were given the vaccine.

Vaxil added that three patients are now free of detectable cancer following the treatment.

The findings support research published in the journal Vaccine, which showed the treatment induced “potent” immunity in mice and increased their survival from cancer.

Cancer charities have given the vaccine a cautious welcome, but warned further testing was needed before it could be approved for widespread use.

There are currently a number of other therapeutic vaccines against cancer being tested, but they have met with limited success.

Dr Kat Arney, science information manager at Cancer Research UK, said: “There are several groups around the world investigating treatments that target MUC1, as it’s a very interesting target involved in several types of cancer.

“These are very early results that are yet to be fully published, so there’s a lot more work to be done to prove that this particular vaccine is safe and effective in cancer patients.” …

CONTINUED at The Telegraph.

The Obama administration is quietly diverting roughly $500 million to the IRS to help implement the president’s healthcare law.

The money is only part of the IRS’s total implementation spending, and it is being provided outside the normal appropriations process. The tax agency is responsible for several key provisions of the new law, including the unpopular individual mandate.

Republican lawmakers have tried to cut off funding to implement the healthcare law, at least until after the Supreme Court decides whether to strike it down. That ruling is expected by June, and oral arguments last week indicated the justices might well overturn at least the individual mandate, if not the whole law.

“While President Obama and his Senate allies continue to spend more tax dollars implementing an unpopular and unworkable law that may very well be struck down as unconstitutional in a matter of months, I’ll continue to stand with the American people who want to repeal this law and replace it with something that will actually address the cost of healthcare,” said Rep. Denny Rehberg (R-Mont.), who chairs the House Appropriations subcommittee for healthcare and is in a closely contested Senate race this year.

The Obama administration has plowed ahead despite the legal and political challenges.

It has moved aggressively to get important policies in place. And, according to a review of budget documents and figures provided by congressional staff, the administration is also burning through implementation funding provided in the healthcare law.

CONTINUED at The Hill.

President Barack Obama took an opening shot at conservative justices on the Supreme Court on Monday, warning that a rejection of his sweeping healthcare law would be an act of “judicial activism” that Republicans say they abhor.

Obama, a Democrat, had not commented publicly on the Supreme Court’s deliberations since it heard arguments for and against the healthcare law last week.

Known as the “Affordable Care Act” or “Obamacare,” the measure to expand health insurance for millions of Americans is considered Obama’s signature domestic policy achievement.

A rejection by the court would be a big blow to Obama going into the November 6 presidential election.

Republican presidential candidates, who are vying to take on Obama in November elections, have promised to repeal the law if one of them wins the White House.

Obama’s advisers say they have not prepared contingency plans if the measure fails. But the president — who expressed confidence that the court would uphold the law — made clear how he would address it on the campaign trail if the court strikes it down.

“Ultimately, I am confident that the Supreme Court will not take what would be an unprecedented, extraordinary step of overturning a law that was passed by a strong majority of a democratically elected Congress,” Obama said at a news conference with the leaders of Canada and Mexico.

CONTINUED at Reuters.

The Supreme Court’s conservative justices said Wednesday they are prepared to strike down President Obama’s healthcare law entirely.

Picking up where they left off Tuesday, the conservatives said they thought a decision striking down the law’s controversial individual mandate to purchase health insurance means the whole statute should fall with it.

The court’s conservatives sounded as though they had determined for themselves that the 2,700-page measure must be declared unconstitutional.

“One way or another, Congress will have to revisit it in toto,” said Justice Antonin Scalia.

Agreeing, Justice Anthony Kennedy said it would be an “extreme proposition” to allow the various insurance regulations to stand after the mandate was struck down.

Meanwhile, the court’s liberal justices argued for restraint.Justice Ruth Bader Ginsburg said the court should do a “salvage job,” not undertake a “wrecking operation.” But she looked to be out-voted.

Chief Justice John G. Roberts Jr. and Justice Samuel A. Alito Jr. said they shared the view of Scalia and Kennedy that the law should stand or fall in total. Along with Justice Clarence Thomas, they would have a majority to strike down the entire statute as unconstitutional.

CONTINUED at the LA Times.